ResMed demonstrated strong financial and operational performance in Q2 2025, supported by double-digit growth across key segments and expanding gross margins. The AirSense 11 platform and AirTouch ...
ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback